Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Primary tumor cancer cells are the original malignant epithelial or mesenchymal-derived neoplastic cell populations that initiate uncontrolled growth within an organ. These heterogeneous populations exhibit diverse genetic and phenotypic profiles that influence their ability to proliferate, invade surrounding tissue, evade programmed cell death, interact with stromal components including blood vessels and immune system elements, and ultimately disseminate through lymphatic or hematogenous routes causing metastases. Molecular studies reveal distinct transcriptional signatures associated with metastatic competence involving processes like epithelial-mesenchymal transition (EMT), altered adhesion molecules, chemotaxis factors, KRAS signaling pathways among others. The complexity within these cellular populations poses significant challenges for effective targeted therapy since subclones may differ markedly in drug sensitivity. Understanding their biology through genomic profiling enables personalized treatment approaches aiming both at controlling local disease burden and preventing distant spread.
Drugs act by: Inhibiting cell division/proliferation; Inducing apoptosis or cell death pathways; Blocking signaling pathways critical for survival/growth (e.g., KRAS signaling, EGFR pathway); Enhancing immune-mediated killing by overcoming immune evasion mechanisms such as HLA gene methylation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Primary tumor cancer cells (null).